🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

22 recruiting trials

for Treatment Resistant Schizophrenia

Magnetic Seizure Therapy for Schizophrenia - Trial NCT06672588NA2 sites📍 Vancouver📍 Toronto Centre for Addiction and Mental Health · Tests: Magnetic Seizure Therapy (MST), Electroconvulsive Therapy (ECT) Medical Phenotyping of NHS General Adult Psychiatry (GAP) Inpatients NCT07398365n/a1 site📍 Livingston University of Edinburgh · Tests: Questionnaires, rating scales, & review of notes Reduction of Auditory-Verbal Hallucinations in Schizophrenia Through Cortical Neuromodulation NCT06361160NA1 site📍 Paris Centre Hospitalier St Anne · Tests: Active Transcranial Magnetic Stimulation (TMS), Sham Transcranial Magnetic Stimulation (TMS) French Minds Cohort: a French Longitudinal and Multimodal Cohort of Patients With Major Mood Disorders, Psychotic Disorders, Autism Spectrum Disorders, and Healthy Controls NCT07881016NA17 sites📍 Besançon📍 Bordeaux📍 Brest Fondation FondaMental · Tests: 3T Brain MRI, Biological Sampling, Clinical, Cognitive and Digital Assessments Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia NCT07184619Phase 319 sites📍 Los Angeles📍 Miami📍 Atlanta Newron Pharmaceuticals SPA · Tests: Evenamide 15 mg bid, Placebo Cognitive Behavioral Therapy for Sleep and Circadian Disturbances (CBT-I) in Treatment-Resistant Schizophrenia NCT06749444NA1 site📍 Glostrup, Denmark Jimmi Nielsen · Tests: CBT-I, CBT Neuronavigated rTMS for Treatment-Resistant Auditory Hallucinations NCT07856368NA1 site📍 Zurich Psychiatric University Hospital, Zurich · Tests: Neuronavigated repetitive transcranial magnetic stimulation (rTMS), Sham repetitive transcranial magnetic stimulation (… Cognitive and Metacognitive Evaluation in VR-Based Avatar Therapy for Psychosis NCT07091344NA1 site📍 Barcelona Fundació Sant Joan de Déu · Tests: VR-Based Avatar Therapy with Cognitive and Metacognitive Assessments Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial NCT06456983NA14 sites📍 Aachen📍 Augsburg📍 Göppingen Central Institute of Mental Health, Mannheim · Tests: maintenance electroconvulsive therapy (mECT) Deep Brain Stimulation for Psychosis NCT06257056NA1 site📍 Dallas Bradley Lega · Tests: Abbott Laboratories Infinity™ implantable deep brain stimulation system Effects of Nitraria Retusa Infusion on Clozapine-induced Metabolic Side Effects NCT07817069NA1 site📍 Sousse Faculty of Medicine, Sousse · Tests: The Nitraria retusa arm Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium Benzoate NCT06340789Phase 21 site📍 Chiayi City National Cheng-Kung University Hospital · Tests: Sodium Benzoate 2gram/day, Placebo The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment. NCT05958875Phase 413 sites📍 Innsbruck📍 Augsburg📍 Bielefeld Dr. Inge Winter · Tests: Clozapine, Second-line Antipsychotics (treatment as usual) fMRI-based Neurofeedback to Relieve Drug-resistant Auditory Hallucinations NCT04798131NA1 site📍 Lille University Hospital, Lille · Tests: Active neurofeedback procedure, Sham neurofeedback procedure An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults NCT03094429Phase 2, Phase 31 site📍 Pasadena SyneuRx International (Taiwan) Corp · Tests: NaBen®, Placebo Real-time fMRI Neurofeedback in Patients With Schizophrenia and Auditory Hallucinations NCT05299749NA1 site📍 Brockton Boston VA Research Institute, Inc. · Tests: stg-rt-fMRI-Neurofeeback, sham-rt-fMRI-Neurofeedback Evaluation of the Efficacy of Transcranial Magnetic Stimulation on Resistant Auditory Hallucinations in Schizophrenia NCT06599372NA1 site📍 Neuilly-sur-Marne Dominique JANUEL · Tests: The rTMS method, The cTBS method Acetazolamide for Treatment Resistant Schizophrenia NCT04887792Phase 1, Phase 22 sites📍 Pittsburgh📍 Bangalore Vishwajit Nimgaonkar, MD PhD · Tests: Acetazolamide, Placebo Dundrum Forensic Redevelopment Evaluation Study: D-FOREST Study. NCT05074732n/a1 site📍 Dublin Health Service Executive, Ireland Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia NCT05240976Phase 21 site📍 Taichung China Medical University Hospital · Tests: NMDAE plus AIFA, NMDAE plus Placebo Cap SEEG-Guided DBS for Schizophrenia NCT07671261NA1 site📍 Shanghai Ruijin Hospital · Tests: SEEG implantation, Deep brain stimulation Treatment Resistance in Psychiatric Disorders: the Search for Biological Markers Predictive of Response to Treatment NCT07741981NA1 site📍 Paris Centre Hospitalier St Anne · Tests: Blood sampling, lumbar puncture, stool sampling, skin microbiopsy and psychometrics scales
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy